The statement that "mutations in gene X cause disease Y" is a hypothesis to be tested, not a statement of fact. For inherited diseases such as retinal dystrophies, one substantiating piece of evidence is the presence of a putative disease-causing mutation in more than one family with the same disease. In this issue, Arno et al.^[@i1552-5783-57-11-4814-b01]^ provide an instructive example of a possible flaw in this argument: if all affected families share the same mutation, then the mutation may have arisen in a shared, common ancestor and, therefore, another mutation physically close to the hypothetical cause may be the actual cause. A shared mutation arising from a common ancestor is a founder mutation, and variants close to the mutation are in linkage disequilibrium with each other. Even for mutations that arose many generations ago, the region of linkage disequilibrium is hundreds-of-thousands of base pairs in length, encompassing many genes. Arno et al.^[@i1552-5783-57-11-4814-b01]^ report next-generation sequencing in families with inherited retinal dystrophies; among the families, six have a homozygous mutation in the *RGR* gene on chromosome 10q, which codes for an RPE-specific G protein-coupled receptor. The *RGR* mutation, *Ser66Arg*, was first reported by Morimura et al.^[@i1552-5783-57-11-4814-b02]^ as the probable cause of disease in one of the families. However, Arno et al.^[@i1552-5783-57-11-4814-b01]^ also found a frame shift mutation in a nearby gene, *CDHR1*, a gene previously associated with recessive rod--cone dystrophy.^[@i1552-5783-57-11-4814-b03],[@i1552-5783-57-11-4814-b04]^ Based on several lines of evidence, the *CDHR1* mutation is the probable cause of disease in these families and the *RGR* mutation is a rare, benign variant in linkage disequilibrium. This brings into question whether mutations in *RGR* do, in fact, cause recessive retinal disease, and suggests that other one-off mutations may not be pathogenic, in spite of published reports to the contrary.
